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resistance, multiple organ failure, and neoplasm (Ash-
kenazi and Dixit, 1998; Leonen, 1998; Newton and De-
cicco, 1999).
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region contains a death domain. Receptors that containWeill Medical College and
death domains are known as death receptors (Nagata,Graduate School of Medical Sciences of
1997; Ashkenazi and Dixit, 1998). The best studied deathCornell University
receptors are TNFR1 and Fas; while TNFR1 only inducesNew York, New York 10021
cell death under certain circumstances and more often³Oncological Sciences
induces transcriptional gene activation, Fas is efficientHuntsman Cancer Institute
in cell death induction. TNF receptors that do not containUniversity of Utah
death domains are represented by TNFR2, CD40, CD30,Salt Lake City, Utah 84132
and many others. These receptors are involved primarily
in gene transcription for cell survival, growth, and differ-
entiation.
Summary The cell activation, cell survival, and antiapoptotic
functions of the TNF receptor superfamily are mostly
mediated by the family of TNF receptor±associated fac-TRAF proteins are major mediators for the cell activa-
tors (TRAF1±6) (Arch et al., 1998). The TRAF proteinstion, cell survival, and antiapoptotic functions of the
are also genetically conserved across other multicellularTNF receptor superfamily. They can be recruited to
organisms including Drosophila (Liu et al., 1999), C. ele-activated TNF receptors either by direct interactions
gans (Wajant et al., 1998), and Dictyostelium discoideumwith the receptors or indirectly via the adaptor protein
(Regnier et al., 1995). The downstream effectors of TRAFTRADD. We now report the structure of the TRADD-
signaling are transcription factors in the NF-kB and AP-1TRAF2 complex, which is highly distinct from recep-
family (Malinin et al., 1997; Nishitoh et al., 1998; Baudtor±TRAF2 interactions. This interaction is significantly
et al., 1999), which can turn on numerous genes involvedstronger and we show by an in vivo signaling assay
in various aspects of cellular and immune functions. Inthat TRAF2 signaling is more readily initiated by
addition, the activation of NF-kB and AP-1 have beenTRADD than by direct receptor±TRAF2 interactions.
shown to render cells protection from apoptosis via theTRADD is specific for TRAF1 and TRAF2, which en-
transcription of antiapoptotic genes (Beg and Baltimore,sures the recruitment of cIAPs for the direct inhibition
1996; Minden and Karin, 1997).of caspase activation in the signaling complex. The
Both subgroups of the TNF receptor superfamily canstronger affinity and unique specificity of the TRADD±
recruit TRAF proteins. Those without death domainsTRAF2 interaction are crucial for the suppression of
recruit many TRAF family members directly for signalapoptosis and provide a mechanistic basis for the per-
transduction (Rothe et al., 1994; Arch et al., 1998). Deathturbation of TRAF recruitment in sensitizing cell death
receptors related to TNFR1, but not Fas, recruit TRAF2induction.
indirectly via the N-terminal domain of the adaptor pro-
tein TRADD (Hsu et al., 1996b). TRADD also contains a
Introduction death domain and interacts with the intracellular death
domain of TNFR1 via homotypic associations (Hsu et
The TNF receptor superfamily consists of more than 20 al., 1995). The death domain of TRADD is multifunctional
structurally related type I transmembrane proteins that and capable of recruiting two additional signaling pro-
are specifically activated by the corresponding super- teins, FADD and RIP (Hsu et al., 1996a, 1996b). FADD
can directly recruit and activate caspase-8, giving risefamily of TNFa-like cytokines, eliciting a wide spectrum
to the initiation of apoptosis (Boldin et al., 1996; Muzioof cellular responses including transcriptional gene acti-
et al., 1996). RIP, on the other hand, reinforces the stimu-vation and induction of apoptosis (Smith et al., 1994;
lation of gene transcription by activating the NF-kB sig-Gravestein and Borst, 1998). Members of this receptor
naling pathways (Kelliher et al., 1998).superfamily are widely distributed and play key roles in
Even though the establishment of TRAF proteins asmany crucial biological activities including lymphoid and
common signaling molecules explains the partially over-neuronal development, innate and adaptive immunity,
lapping cellular effects by members of the TNF receptorand maintenance of homeostasis. Agents that manipu-
superfamily, it is not clear whether and how TRAF signal-late the signaling of these receptors are being used or
ing differs between the two subgroups of receptors andshowing promise toward the treatment and prevention
whether these differences may effect different biologicalof many human diseases such as rheumatoid arthritis,
functions. The indirect TRAF recruitment by TRADD ex-coronary heart disease, transplantation rejection, insulin
ists in the context of the opposing proapoptotic and
antiapoptotic pathways. Targeted gene deletion has im-
plicated TRAF2 as essential for the suppression of the§ To whom correspondence should be addressed (e-mail: haowu@
med.cornell.edu). intrinsic apoptotic tendency of the TNFR1 signaling
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complex (Yeh et al., 1997), but the precise mechanism of the cap and its coiled-coil domain as the stalk (Park et
al., 1999). Each TRADD-N contacts one protomer of thethis function has not been well established. In addition,
there appear to be differences in the abilities of different TRAF domain only. The binding is at the b sandwich
domain, away from the coiled-coil domain. This interac-TNF receptors in responding to soluble versus cell-
bound forms of ligands. tion of TRADD-N with the TRAF domain at the upper
rim of the mushroom cap adds a wing-like structure toHere, we use structural studies as leads, in conjunc-
tion with further biological experiments, to expand our the mushroom (Figure 1B). The 3-fold axis of the com-
plex coincides with the crystallographic 3-fold axis inunderstanding on this complex network of TRAF signal-
ing. By determining the crystal structure of the complex the crystal, suggesting that the complex obeys near
perfect symmetry in solution.between the N-terminal domain of TRADD (TRADD-N)
and the TRAF domain of TRAF2, we reveal a novel mode The TRADD-TRAF2 complex can be placed in the
large postreceptor signaling complex of TNFR1 andof interaction mediated by a relatively extensive protein±
protein interface. This is distinct from the linear motif± used to suggest the relative locations and proximities
of the signaling molecules (Figure 1D). The carboxylmediated receptor±TRAF2 interactions shown earlier by
us and others (McWhirter et al., 1999; Park et al., 1999; terminus of TRADD-N projects up and away from the
TRADD-TRAF2 complex when viewed in the orientationYe et al., 1999). We further show by characterizing the
native and mutant TRADD±TRAF2 interactions using shown in Figure 1B. The direction of the projection is
likely to indicate the possible location of the carboxy-biosensor measurements that this novel form of TRADD±
TRAF2 interaction confers significantly higher affinity terminal death domain of TRADD, which directly binds
the intracellular death domain of TNFR1. This fixes theand distinct specificity in comparison with receptor±
TRAF2 interactions. The higher affinity of the TRADD± orientation of the complex relative to the cellular mem-
brane (Figures 1B and 1D). The death domain of TRADDTRAF2 interaction suggests that TRADD is a stronger
inducer of TRAF2 signaling, which we further confirm is the central platform for recruiting other intracellular
signaling molecules such as FADD for caspase-8 bind-experimentally in vivo. This affinity difference also pro-
vides a structural basis for the different avidity require- ing and activation and RIP for NF-kB activation. The
amino-terminal effector domain of TRAF2 would alsoments of direct TRAF signaling versus TRADD-mediated
TRAF signaling. In contrast with the rather promiscuous locate more intracellularly for engaging those molecules
required for JNK and NF-kB activation. More impor-interactions of receptors with many members of the
TRAF family, we show that TRADD is specific for TRAF1 tantly, the coiled-coil domain of TRAF2, which is respon-
sible for its interaction with cIAPs, would likely situateand TRAF2. This specificity of TRADD suggests a more
prominent role of the cellular caspase inhibitors cIAPs close to the FADD-recruited caspase-8 in this signaling
complex.for the immediate inhibition of caspase activation in the
multifunctional signaling complex of TNFR1, as cIAPs
are constitutively associated with these two TRAF pro- The Bipartite TRADD-TRAF2 Interaction Occupies
teins only. Therefore, any perturbation on TRAF-medi- a Similar Surface of TRAF2 but Bears No
ated recruitment of cIAPs to the TNFR1 signaling com- Resemblance to Receptor-TRAF2 Interactions
plex may sensitize TNFR1-induced apoptosis. We show The interface between TRADD-N and the TRAF domain
that the high affinity, and perhaps the specificity, of the of TRAF2 possesses dual ªridge into grooveº contacts,
TRADD-TRAF2 interaction, is crucial for the suppression which serve to divide the interface into two partially
of apoptosis. connected regions (Figure 2). Region I is smaller in sur-
face area but largely hydrophobic. It is mediated by the
exposed shallow face of the b sheet of TRADD and aResults and Discussion
surface protrusion of TRAF2 formed by b7, the following
loop and the connection between b3 and b4. Region II ofCrystal Structure of the TRADD-TRAF2 Complex
and Its Placement in the Postreceptor the interface is mediated by a highly charged prominent
ridge formed by TRADD residues 143±149 in the EF loopSignaling Complex of TNFR1
Crystal structure of the complex between TRADD-N and and a surface depression of TRAF2 presented by strand
b6 and the following loop. This hydrophilic interface isthe TRAF domain of TRAF2 was determined at 2.0 AÊ
resolution using multiwavelength anomalous diffraction rich in hydrogen bonds and salt bridges. In addition,
there are many water-mediated interactions in this re-of the selenomethionyl crystal. TRADD-N folds into an
a-b sandwich with a four-stranded b sheet and six a gion and the boundary between regions I and II.
The protein±protein interface of the TRADD±TRAF2helices, each forming one layer of the structure (Figure
1A). The basic polypeptide topology of TRADD-N has interaction occupies a similar surface at the edge of the
b sandwich of TRAF2 in comparison with receptor±been observed in other protein structures (Orengo and
Thornton, 1993). However, TRADD-N shares no recog- TRAF2 interactions determined previously (McWhirter
et al., 1999; Park et al., 1999; Ye et al., 1999). This indi-nizable sequence homology to any known structures
and is much more elaborate with only approximately cates the competitive nature of direct and indirect
TRAF2 recruitment by the TNF receptor superfamily.half of its residues superimposable with its structural
neighbors. However, the actual molecular contacts of TRAF2 with
TRADD and with receptors are entirely different. In allThe trimeric TRAF domain of TRAF2 imposes a 3-fold
symmetry to the stoichiometrically bound TRADD-N six different receptor±TRAF2 complexes, the receptor
peptides exhibit an extended main chain conformation(Figures 1B and 1C). The TRAF domain of TRAF2 has
the shape of a mushroom when viewed along a vertically to form an additional strand adjacent to the edge of
the b sandwich of TRAF2 through main chain hydrogenorientated 3-fold axis, with its b sandwich domain as
Structural Analyses of the TRADD±TRAF2 Interaction
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Figure 1. Structural Overview of TRADD-N and the TRADD-N/TRAF2 Complex
(A) Ribbon representation of TRADD-N, showing the two-layer arrangement of the a-b sandwich. Helices are colored yellow (A-F), b strands
blue (1±4), and loops green. The b sheet is entirely antiparallel and slightly twisted with a strand order of b2, b3, b1, and b4. There are two
helices each in the b1-b2 and b3-b4 cross-over connections while the b2-b3 connection is hairpin-like. The remaining two helices (E and F)
are near the carboxyl terminus of the domain; the loop in between (EF loop) partly covers one end of the exposed face of the b sheet. A
single hydrophobic core is present in TRADD-N between the buried face of the b sheet and the opposing a helices. The closed nature of this
hydrophobic core supports that this domain folds independently of the carboxy-terminal death domain.
(B and C) Ribbon representations of the TRADD-N/TRAF2 complex, showing with the 3-fold axis vertical in (B) and into the page in (C). Three
molecules of TRADD-N are shown respectively in magenta, red, and yellow. The protomers of the trimeric TRAF domain of TRAF2 are shown
respectively in cyan, green, and dark blue. The death domain of TRADD (TRADD-C) is proposed to be locate above the C-terminal helix of
TRADD-N in (B).
(D) A hypothetical molecular arrangement in the signaling complex of TNFR1 and related death receptors. The cell membrane is represented
in yellow. The trimeric TNFa, shown by ovals, mediates TNFR1 trimerization. TNFR1 is shown by straight rectangles, while FADD and RIP are
shown by bent rectangles. Death domains in TNFR1, TRADD (labeled as TRADD-C), FADD, and RIP are shaded in gray. TRADD-N and the
TRAF domain of TRAF2 are highlighted using the same color-coding in (B) and (C). cIAPs (oval shape) are recruited by TRAF2 and shown to
inhibit caspase activation by this signaling complex. For clarity, only single molecules of FADD and RIP are shown, even though they are
expected to multimerize in the signaling complex.
bonding interactions. Specific side chain interactions TRAF2. Receptor peptides appear to undergo signifi-
cant conformational changes upon binding to TRAF2define linear TRAF2 binding motifs, which are absent in
the TRADD sequence. (Ye and Wu, 2000). We suspect that TRADD-N (espe-
cially the EF loop) may also undergo a certain degreeThe interaction between TRADD and TRAF2 buries a
total of 1500 AÊ 2 surface area, in contrast with the smaller of conformational rearrangement upon TRAF2 binding
based on the relative instability of TRADD-N in its iso-peptide±protein contacts in receptor±TRAF2 interac-
tions. There are small local conformational adjustments lated state.
in the Ca positions of TRAF2 (0.5±1.0 AÊ ) within or imme-
diately adjacent to the TRADD binding site, while no
significant local conformational changes have been ob- Biosensor Measurements Reveal the Significantly
Higher Affinity of the TRADD±TRAF2 Interaction,served in the receptor-bound TRAF2 structures. In both
cases, overall structural superpositions between the Contributed Mostly by Hydrophobic Contacts
To characterize the affinity and the energetic determi-bound and several free TRAF domain structures of
TRAF2 gave rise to main chain deviations similar with nants of the TRADD±TRAF2 interaction, surface plas-
mon resonance biosensor analyses were used to assessobserved variations among different crystal forms of
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Figure 2. Structural Details of the TRADD-N/TRAF2 Complex
(A) Bipartite interacting surfaces formed by neighboring regions of the proteins. The TRADD-N structure is shown in the same orientation as
the magenta-colored TRADD-N, while the TRAF domain of TRAF2 is rotated 1808 along the vertical axis relative to the cyan protomer in Figure
1B. The surface representations are colored based on their surface electrostatic potentials. The ribbon drawings have the color coding of red
for residues involved in the interaction. (B), (C), and (E) are rotated approximately 908 along the vertical axis relative to (A), and (D) has an
orientation similar to (A). Ribbons of TRADD-N are shown in magenta and the TRAF domain of TRAF2 in cyan. For stick models, either the
entire side chains or the carbon atoms are shown in yellow for TRADD-N and gray for the TRAF domain of TRAF2. Standard color coding
applies to other atoms. Water molecules are represented by red balls. Labels for TRADD-N are in magenta and those for the TRAF domain
of TRAF2 in cyan. (B) A ribbon drawing of the complex. Selected side chains and water molecules at the interface are shown. Approximate
locations of the enlargements in (C), (D) and (E) are circled and labeled. (C) Details of the lower part of the interface (region I), showing the
hydrophobic interactions. The interface is represented by a ribbon drawing, showing side chains involved in the interaction. (D) Details of the
upper part of the interface (region II), showing the polar interactions. The interface is represented by a stick model. Part of the main chain
that is not involved in the polar interaction is simply shown by the Ca trace. Potential hydrogen bonds and salt bridges are represented by
yellow dotted lines. Residues 145±147 of TRADD form antiparallel main chain hydrogen bonds with residues 448±450 of TRAF2 in the connection
between b6 and b7. Many side chain hydrogen bonds and salt bridges exit at this interface including the bidentate hydrogen bonds between
the guanidinium group of R146 in TRADD and the carboxylate of D445 in TRAF2. (E) Details of water-mediated interactions near the center
of the interface. Most of these interactions are between the polar and charged side chain atoms of TRADD and the polar main chain atoms
of TRAF2 at the edge of the b sandwich. In addition to bridging the TRADD-TRAF2 interface, the water molecules may also provide hydration
to the polar and charged atoms in the vicinity.
the native interaction and the effects of TRADD-N muta- is further supported by the significant affinity enhance-
ment in the binding of trimeric TRAF2 to Biosensor chipstions (Figure 3). To avoid potential avidity effects, the
trimeric TRAF domain of TRAF2 was coupled to the coupled with increasing densities of TRADD-N (data not
shown).biosensor chip to measure the binding of monomeric
TRADD-N. The native interaction gave rise to a dissocia- Residues in regions I and II showed differential effects
on the binding affinity, in a manner unrelated to theirtion constant of 7.8 6 3.6 mM with an on-rate of 1.65 6
0.7 3 105 M21s21 and an off-rate of 1.3 6 0.2 s21. This surface area burial at the interface (Figure 3). In general,
alanine substitutions of residues in region I (Y16, F18,interaction is significantly stronger than direct receptor±
TRAF2 interactions (KD 5 40 mM±1.0 mM) (Ye and Wu, H65, and S67) had much more drastic effects, despite
their smaller surface area contribution. This may be ex-2000). However, it is still rather weak compared to other
protein±protein interactions (Kuriyan and Cowburn, 1997), plained by their complete solvent inaccessibility in the
complex and the largely hydrophobic nature of the con-which is indicative of the importance of multimeric inter-
action in this TRAF2 recruitment and in the assembly of tact. Residues in region II were selected for their large
surface area burial and their abilities to form direct andthe TNFR1 signaling complex. The importance of avidity
Structural Analyses of the TRADD±TRAF2 Interaction
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Figure 3. Energetics of the Interaction
(A) Mapping of structural features onto the
TRADD-N sequence. The first line is human
TRADD and the second line is mouse TRADD
with identical residues shown as dashes. Sol-
vent accessibility of each TRADD-N residue
when the TRAF2 structure is pulled away is
shaded below the sequences. Residues in-
volved in TRAF2 interaction are colored
based on their total surface area burials and
those completely buried at the interface are
labeled by asterisks. TRADD residues in-
volved in TRAF2 interaction are almost en-
tirely identical between the human and
mouse sequences, suggesting a functional
conservation among the mammalian species.
(B) Characterization of the interactions of
wild-type and mutant TRADD-N with wild-
type TRAF domain of TRAF2 using biosensor
analysis. The dissociation constants (KD) in
mM and relative to the wild-type interaction
are shown, as well as the calculated DDG of
the mutational effects (258C).
(C) TRAF2-interacting surface of TRADD-N.
Region I is shown in cold colors (light blue,
blue, dark blue, green, and purple) and region
II in different shades of red. Colors for each
mutated residue follow the same text color
in (B).
water-mediated hydrogen bonds or salt bridges at the whether other TRAF family members may also interact
interface (Q143, D145, R146, and L147). Rather unex- with TRADD. Existing experimental data have produced
pectedly, mutations on Q143, D145, and L147 had mini- conflicting results regarding this specificity (Hsu et al.,
mal effects on the binding energy (#3-fold). The only 1996b; Shu et al., 1996). The availability of the crystal
residue that exhibits a large effect is R146, which forms structure allowed us to resolve this issue by careful
buried bidentate hydrogen bonds and a salt bridge to examination of the sequence conservation among dif-
residue D445 of TRAF2. For most of the mutations in ferent TRAF proteins at the TRADD-N binding site fol-
both regions I and II, the direct removal of a particular lowed by structure-based mutagenesis. These ªswitch-
interaction rather than local conformational perturbation ingº mutations from residues in TRAF2 to corresponding
accounts for a majority of the effects. This is supported residues in other TRAF family members (Figure 4) were
by the additive nature of the DDG of TRADD-N mutants then assessed by biosensor measurements.
and the DDG of TRAF2 mutants, as compared with the The severe effects of TRAF2 mutations T401M, L471K,
measured DDG between mutant TRADD-N and mutant and L471R (Figures 4B and 4C) established that TRAF3,
TRAF2 proteins (data not shown). Therefore, it appears TRAF4, and TRAF5 have much decreased ability to inter-
that region I is the primary energetic determinant of the
act with TRADD. Both T401 and L471 constitute part ofinteraction, while region II contributes less, perhaps due
the region I of the interaction and are completely buriedto the plasticity afforded by water-mediated interac-
at this mostly hydrophobic interface (Figure 4A). There-tions. The electrostatic nature of region II, on the other
fore, the bulkier size of M401 and the charge of K/R471hand, may provide long-range attraction forces to facili-
could create unfavorable contacts in the interaction.tate the interaction.
In TRAF6, almost all TRADD-interacting residues are
substituted, including residues T401 and L471. In addi-Swapping Mutagenesis Shows the Specificity
tion, mutations D450K and S467F also had unfavorableof TRADD for TRAF1 and TRAF2: Implication
effects on the interaction. The predicted additive effectsfor the Recruitment of cIAPs
of this double mutation alone could lead to a DDG of 2to the Signaling Complex
kcal/mol, corresponding to a 30-fold decrease in affinity.To fully elucidate the functional consequence of the
TRADD±TRAF2 interaction, it is important to establish The only TRAF family member that appears to retain the
Cell
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Consistently, Q143A mutation on TRADD also had mini-
mal effect on the binding (Figure 3B), perhaps due to
the plasticity of region II of the interface. The avidity
contribution during assembly of the signaling complex
should further enhance the specificity of TRADD for
TRAF1 and TRAF2, as compared with the affinity differ-
ences shown in the monovalent interactions.
The specificity of TRADD for TRAF1 and TRAF2 en-
sures the recruitment of cIAPs to the signaling complex,
which may be important for direct caspase-8 inhibition
(Wang et al., 1998) and the immediate suppression of
apoptosis at the apical point of the cascade (Figure 1D).
The cellular caspase inhibitors cIAP1 and cIAP2 were
originally isolated from the TNFR2 signaling complex
and shown to interact constitutively with TRAF1 and
TRAF2 (Rothe et al., 1995). This interaction is rather
unique as other inhibitors of apoptosis proteins (IAPs)
do not interact with any TRAF proteins and other TRAF
proteins do not interact with cIAPs (Roy et al., 1997). In
addition, this interaction with cIAPs requires both TRAF1
and TRAF2 (Rothe et al., 1995). Therefore, like TRADD,
the cIAPs have the same specificity for TRAF1 and
TRAF2. This is in contrast with the direct TRAF recruit-
ment by the subgroup of TNF receptors that do not
contain a death domain, which exhibits a more promis-
cuous specificity for TRAF1, 2, 3, and 5 (Park et al.,
1999; Ye et al., 1999). Interestingly, TRAF1 does not
contain an amino-terminal effector domain for survival
signaling via transcriptional gene activation, while other
TRAF proteins such as TRAF5 and TRAF6 do. Therefore,
the inclusion of TRAF1 in the TNFR1 signaling complex
further implicates the importance of cIAPs for the intrin-
sic antiapoptotic function of TNFR1.
Figure 4. Specificity of the Interaction The Higher Affinity of the TRADD-TRAF2 Interaction
(A) Sequence alignment of different human and mouse TRAF family versus the Receptor-TRAF2 Interactions Leads
members at the TRADD binding site. TRAF2 residues involved in to More Effective TRADD-Mediated
TRADD interaction are shaded as in Figure 3A. Identical residues TRAF2 Signaling
in other TRAFs are also colored with the same scheme. Residues
The higher affinity of the TRADD-TRAF2 interactioncompletely buried at the interface are labeled by asterisks.
(KD5 7.8 mM), as compared with the interactions be-(B) Characterization of the interactions of wild-type and mutant
tween TRAF2 and receptor peptides (KD 5 40 mM±1.0TRAF2 with wild-type TRADD-N using biosensor analysis. The disso-
ciation constants (KD) in mM and relative to the wild-type interaction mM) (Ye and Wu, 2000), suggests that TRADD might
are shown, as well as the calculated DDG of the mutational effects be a stronger inducer of TRAF2 signaling. To test this
(258C). U. D., undetectable. hypothesis, we compared TRAF2 signaling from TNFR1,
(C) TRADD-interacting surface of TRAF2. Region I is shown in cold
a TRADD-mediated signaling, and from TNFR2 (KD 5 0.5colors (light blue, dark blue and green) and region II in warm colors
mM for the TNFR2-TRAF2 interaction), a direct receptor-(light red, dark red, magenta, and dark orange). Colors for each
mediated signaling, since both TNFR1 and TNFR2 bindmutated residue follow the same text color in (B).
(D) TRAF2 in complex with a TNFR2 peptide bearing the sequence with high affinity to soluble TNFa.
of QVPFSKEEC (Park et al., 1999). The TNFR2 peptide is shown in As many cell types coexpress TNFR1 and TNFR2, we
a stick model with carbon atoms in yellow, nitrogen atoms in blue, isolated embryonic fibroblasts from mice deficient in
oxygen atoms in red, and sulfur atoms in green. TNFR2-interacting
TNFR1 (Pfeffer et al., 1993) or in TNFR2 (Erickson et al.,surface of TRAF2 is colored in light red for the region in overlap
1994), in order to obtain cells that contain only one ofwith the TRADD-interacting surface and purple for the remaining
the TNF receptors. The number of TNF receptors onregion.
each type of fibroblast was first determined for the nor-
malization of TRAF2 signaling. The binding of each type
of fibroblasts to 125I-labeled TNFa in the absence and
presence of excess cold TNFa was measured. Scatch-ability to interact with TRADD is TRAF1, which contains
almost entirely identical residues at the TRADD binding ard analyses of the binding data showed that the TNFR1-
deficient fibroblasts contain approximately 3800 TNFR2site. The only nonconserved substitution S454A pro-
duced little change in the affinity (Figure 4B), even per cell with a dissociation constant of 0.09 nM and that
the TNFR2-deficient fibroblasts contain z9600 TNFR1though the side chain of S454 appears to mediate a
hydrogen-bonding interaction with Q143 of TRADD. per cell with a dissociation constant of 0.07 nM.
Structural Analyses of the TRADD±TRAF2 Interaction
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The High Affinity of the TRADD±TRAF2 Interaction
Is Required for Efficient Suppression
of Apoptosis
TNFR1 and related death receptors constitute one of
the most intriguing intracellular signaling pathways that
are capable of both cell survival promotion and cell
death induction. Under most circumstances, however,
TNFa treatment rarely induces cell death and the sur-
vival pathway through TRAF2 and RIP appears to domi-
nate the signaling process. TRAF2 signaling plays an
important role in protection of apoptosis as TRAF2-defi-
cient mice are overly sensitive to TNFa-induced cell
death (Yeh et al., 1997). The much higher affinity of
TRAF2 recruitment by TRADD versus the direct TRAF2
recruitment by TNF receptors without a death domain,
suggests the importance of preserving this high affinity
in the signal transduction by TNFR1 and related recep-
tors. Using TRADD mutants with various degrees of af-
finity decrease to TRAF2, we analyzed the effects of
these mutations in providing apoptosis protection.
We selected three single-site mutations of TRADD,
H65A, Y16A, and S67A with decreasing affinities to
TRAF2 (Figure 3B), and tested their apoptosis-inducing
effects in a transfection assay. It has been shown that
TRADD transfection or overexpression could induce sig-
nificant cell death in TNFa-sensitive cell lines such as
L929 (Liou and Liou, 1999). If the interaction between
TRADD and TRAF2 is sensitive to affinity modulation,
TRADD mutants with decreased TRAF2 recruiting capa-
bility would be expected to exert more potent cell death
effects. The experimental results showed that indeed
the TRADD mutants were highly potent in apoptosisFigure 5. Functional Analysis of the Interaction between TRADD
induction, as compared with the wild-type TRADD (Fig-and TRAF2
ure 5B). Only a small percentage of transfected cells(A) Comparison of JNK signaling in fibroblasts containing either
were viable two days posttransfection. The H65A mutantTNFR1 or TNFR2 only. Embryonic fibroblasts unstimulated (0 min)
or stimulated (10 and 30 min) with TNFa were lysed, loaded based exhibits a mere 9-fold decrease in TRAF2 binding and
on normalized receptor numbers, and probed with antibodies falls into the same range of affinities to the interactions
against the doubly phosphorylated JNK (upper panel) and total JNK of TRAF2 with linear receptor motifs. This mutant was
(lower panel). JNK was activated upon TNFa treatment and down- surprisingly as potent in cell killing as the most severeregulation of JNK was observed.
S67A mutant. These data suggest that the in vivo in-(B) TRADD-mediated apoptosis assay. Percentages of apoptotic
teraction between TRADD and TRAF2 is extremely sen-cells and the standard deviations for the control vector (CDM8), the
sitive to affinity changes. A modest decrease in thewild-type TRADD, and TRADD mutants H65A, Y16A, and S67A are
shown. monomeric affinity, which may translate into a larger
difference in the multimeric interaction, could lead to an
imbalance in the regulation between cell survival andAs TRAF2-deficient mice and transgenic mice ex-
cell death.pressing a dominant-negative form of TRAF2 have
There may be two ways that TRAF2 can protect theshown that TRAF2 is the major activator of JNK by TNFa
cells from apoptosis and the cooperation of the two(Lee et al., 1997; Yeh et al., 1997), we used JNK activation
mechanisms may be necessary for efficient apoptosisas the readout for TRAF2-mediated signal transduction.
suppression. The first mechanism has to do with recruit-The primary embryonic fibroblasts were treated with
ment of the cellular caspase inhibitors, cIAP1 and cIAP2,mouse TNFa and the levels of doubly phosphorylated
to the TNFR1 signaling complex by TRAF1 and TRAF2JNK were detected at 10 and 30 min poststimulation
to inhibit caspase-8 activation (Rothe et al., 1995; Wangusing specific anti-phospho-JNK antibodies. The TNFR1-
et al., 1998). This mechanism acts at the entry pointcontaining fibroblasts had significantly higher levels of
of TNFa-mediated apoptosis, is independent of geneJNK activation than the TNFR2-containing fibroblasts
transcription, and explains the specificity of TRADD for(Figure 5A), substantiating TRADD as the more effective
TRAF1 and TRAF2 but not other members of the TRAFinitiator of TRAF2 signaling. The higher level of TRAF2
family. The second mechanism may be related to thesignaling by TNFR1 also indicates an effective interac-
ability of TRAF2 to activate JNK and NF-kB, both oftion between the death domain of TRADD and TNFR1.
which may induce the expression of antiapoptotic genesInterestingly, it has been shown that in the absence of
to suppress cell death (Beg and Baltimore, 1996; Mindenreceptor activation, the death domain of TNFR1 is bound
and Karin, 1997). Since apoptosis induction can be fastto a silencer protein to suppress its tendency to signal
(Jiang et al., 1999). and does not require gene transcription and protein
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Table 1. Structure Determination
MAD Phasing (30±2.1 AÊ )
Cell dimensions: a 5 b 5 131.5 AÊ , c 5 62.8 AÊ (R3)
Diffraction Ratio
Wavelength Energy Rmerge Completeness l1 l2 l3 l4
l1 0.992 AÊ 12500ev 5.6% 80.0% 4.0% 4.4% 4.5% 6.3%
l2 0.979 AÊ 12660ev 5.6% 78.4% 5.0% 4.1% 7.1%
l3 0.979 AÊ 12664ev 5.5% 81.7% 6.5% 5.2%
l4 0.968 AÊ 12820ev 6.0% 85.4% 5.0%
MADSYS statistics D(D`) 5 46.88 RFA 5 41.8%
Refinement (20±2.0 AÊ )
Cell dimensions: a 5 b 5 132.4 AÊ , c 5 62.8 AÊ (R3)
Wavelength Rmerge Completeness Atoms H2O R (Rfree) Rms Bond Rms Angle
0.992 AÊ 3.6% 96.9% 2542 209 22.9 (26.1%) 0.008 AÊ 1.78
synthesis, the first mechanism is likely to be crucial in In these cases, soluble ligands are often inefficient in
eliciting signal transduction and may even act as decoysplacing apoptosis under check while the second mecha-
nism may further strengthen the antiapoptotic function to downregulate the signal (Kehry and Castle, 1994;
Hodgkin et al., 1997).of TRAF2.
The Affinity Differences of TRAF2 Recruitment The Competitive Recruitment of TRAF1, TRAF2,
and the Associated cIAPs in SensitizingReveal the Different Avidity Requirements
for Efficient Signaling TNFR1-Induced Cell Death
Although TNFR2 does not directly couple to apoptosis,It has been indicated that the entire TNF receptor super-
family assembles their intracellular signaling complex in mice deficient in TNFR2 showed decreased cell death
following TNFa treatment (Erickson et al., 1994), whileresponse to ligand-induced receptor trimerization (Ban-
ner et al., 1993) or higher order oligomerization. In partic- overexpression of TNFR2 could lead to increased sensi-
tivity to TNFa-induced apoptosis (Heller et al., 1992;ular, the ligand dependence of TRADD recruitment to
TNFR1 and the sequential binding of TRAF2 following Vandenabeele et al., 1995; Weiss et al., 1997; Haridas
et al., 1998; Chan and Lenardo, 2000). Moreover, TNFa-TRADD recruitment have been demonstrated experi-
mentally (Hsu et al., 1996b; Shu et al., 1996). Therefore, induced apoptosis of activated primary T lymphocytes
has also been shown to require TNFR2 (Sarin et al.,the avidity provided by different degrees of multimeric
interactions, as well as the intrinsic affinity between the 1995; Zheng et al., 1995). Functionally, this may be im-
portant for Fas-independent peripheral deletion of Tsignaling proteins, drive the signal transduction cascade
of this family of receptors. lymphocytes and the regulation of mature T cell homeo-
stasis.The consideration on the combined effects of affinity
and avidity explains why TNFR2 is rather nonresponsive We propose that the observed cooperation of TNFR2
in TNFR1-mediated apoptosis could be explained by ato soluble TNFa but mostly responds to cell-bound TNFa
(Grell et al., 1995), while TNFR1 can be stimulated effi- decreased recruitment of TRAF1, TRAF2, and cIAPs in
the TNFR1 signaling complex. Overexpression or upreg-ciently with soluble TNFa. TNFa is synthesized as a
transmembrane ligand and efficiently converted to solu- ulation of expression of TNFR2 upon T cell activation
could lead to an increased association of TRAF1 andble TNFa under most but not all circumstances. The
affinity of the TNFR2±TRAF2 interaction (KD 5 0.5 mM) TRAF2 with TNFR2, sequestering intracellular TRAF1,
TRAF2, and the constitutively associated cIAPs awayis remarkably lower than the TRADD±TRAF2 interaction.
The cell-bound TNFa may be capable of creating higher from the signaling complex of TNFR1 and related recep-
tors. In keeping with this proposal, the TRAF2 bindingorder of receptor clustering than soluble TNFa and may
therefore provide enhanced avidity to TRAF2 recruit- region of TNFR2 is required for this potentiation of
TNFR1-mediated apoptosis (Weiss et al., 1998).ment by TNFR2 to potentiate this signal transduction.
TNFR2 signaling can also be induced by the upregula- This interplay between TNFR2 and TNFR1 may be
extended to other members of the TNF receptor super-tion of expression, which again increases the avidity
contribution of TRAF2 recruitment. family such as CD40, CD30, LT-bR and CD27. These
receptors have been shown to induce cell death underThe generally weaker affinity between TRAF2 and
many members of the TNF receptor superfamily, such certain circumstances (Grell et al., 1999). Similar to
TNFR2, activation of any of these receptors could leadas CD40, CD30, Ox40, and 4-1BB (KD 5 40 mM±1.0 mM),
implies that a higher order of aggregation may be re- to a sequestration, and possibly degradation (Duckett
and Thompson, 1997), of TRAF1, TRAF2, and cIAPs. Asquired for the optimal signal transduction of these re-
ceptors. In keeping with this observation, the corre- these receptors have been shown to induce the expres-
sion of TNFa (Grell et al., 1999), the thus activated TNFR1sponding ligands for these receptors are membrane
bound, which could induce more aggregation and pro- would be tipped to apoptosis induction under the lack
of recruitment of TRAF1, TRAF2, and cIAPs.vide higher avidity for the receptor±TRAF2 interactions.
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Experimental Procedures For the wild-type interaction, the entire biosensor experiment was
repeated four times using immobilized TRAF2 levels of 300, 500,
800, and 1000 RU. For mutant interactions, each TRAF2 variant wasComplex Formation and Crystallization
Protein preparation for the TRAF domain of human TRAF2 (residues immobilized onto a separate biosensor surface at high response
levels (1200±1300 RU). A separate reference flow cell was activated327±501) was performed as described earlier (Park et al., 1999).
Bacterial expression of the TRAF2 binding domain of TRADD (resi- and blocked to correct for refractive index changes. The experi-
ments were performed at 258C using a flow rate of 100 ml/min.dues 1±169), previously identified from deletion analysis (Hsu et al.,
1996b), yielded protein that was severely prone to aggregation and TRADD-N was injected over the sample and reference flow cells at
concentrations of 60, 20, 6.6, 2.2, 0.74, and 0 mM. The running bufferdid not associate appreciably with purified TRAF domain of TRAF2
in vitro. In contrast, an alternative construct (TRADD-N, residues contained 10 mM HEPES at pH 7.4, 150 mM NaCl, 3.4 mM EDTA,
and 0.005% Tween 20. Each concentration of TRADD-N was in-7±163), designed based on amino acid sequence analysis (Rost and
Sander, 1994), gave rise to a monomeric protein under overnight jected three times in random order. No regeneration condition was
required as the bound TRADD-N dissociated back to baseline in ainduction at 208C. The protein contained a carboxy-terminal polyhis-
tidine tag and was purified by nickel affinity chromatography and few seconds.
Binding data were prepared for kinetic analysis by subtractinggel filtration. For complex formation, slightly excess TRADD-N was
incubated with the TRAF domain of TRAF2 at 378C for 30 min. The responses from the reference surface and average blank injections
(Myszka, 1999). The association and dissociation phase data wereresulting mixture was further purified by gel filtration. The complex
exhibited much improved stability over isolated TRADD-N. fitted simultaneously to a single bimolecular interaction model (A 1
B 5 AB) using program CLAMP (Morton and Myszka, 1998; MyszkaThe complex between TRADD-N and the TRAF domain of TRAF2
was crystallized by vapor diffusion using 11% PEG4K and 4% iso- and Morton, 1998). The standard deviations of the measurements
were determined from averaging four independently fitted parame-propanol at pH 5.6. Although crystals may be obtained with PEG4K
alone, the addition of isopropanol dramatically improved the diffrac- ters for the wild-type interaction and from statistical errors of a
single global fitting for the mutant proteins.tion limit from 3.0 AÊ to 2.4 AÊ using a rotating anode X-ray source.
There are seven methionine residues in the TRAF domain of TRAF2
and only one in TRADD-N. Therefore, the TRAF domain of TRAF2
Scatchard Analysis for the Binding of TNFawas produced in the selenomethionyl form (Hendrickson et al., 1990)
to Embryonic Fibroblastsfor MAD phasing using selenium-containing crystals. These crystals
Recombinant mouse TNFa (Pepro Tech) was labeled by 125I to adiffracted to 2.0 AÊ spacing under synchrotron radiation and belong
specific activity of 1.7 3 108 cpm/nmol. Embryonic fibroblasts wereto space group R3 with one complex per crystallographic asymmet-
isolated from mice deficient in TNFR1 or TNFR2 (Jackson Labora-ric unit. The molecular 3-fold axis of the complex coincides with the
tories) and maintained in DMEM supplemented with 15% fetal bo-crystallographic 3-fold axis.
vine serum. Binding of 125I-TNFa to TNFR1- or TNFR2-containing
fibroblasts (0.25 3 106 and 0.36 3 106 cells, respectively) was carriedStructure Determination
out at 48C in 6-well culture dishes at concentrations of 0.075 nM,Crystal structure of the complex was phased by MAD analysis and
0.15 nM, 0.3 nM, 0.6 nM, and 1.2 nM in PBSA, both in the absencepartial model phase combination (Table 1). The MAD data set was
and presence of 20-fold excess unlabeled TNFa. The binding mix-collected at the HHMI X4A beamline of NSLS using a Quantum 4
tures were incubated for 2 hr with gentle rocking. The unboundCCD detector. Four wavelengths were chosen for the experiment:
TNFa was then washed off and the cells were dissolved in 1 M NaOH12500ev (0.992 AÊ , l1, low energy remote), 12660ev (0.979 AÊ , l2,
for counting. The binding data were then subjected to standardedge), 12664ev (0.979 AÊ , l3, peak), and 12820ev (0.968 AÊ , l4, high
Scatchard analyses to determine receptor numbers and bindingenergy remote). The data set was somewhat incomplete due to
affinities.crystal decay. A complete data set at 2.0 AÊ resolution from another
selenomethionyl crystal was collected at 12500ev, which was used
for phase and model refinement. Data processing was carried out JNK Signaling Assay for Mice Deficient
in the HKL package (Otwinowski, 1990). The scaled reflections were in TNFR1 or TNFR2
left unmerged for subsequent MAD phasing. For JNK signaling assay, cells were plated at 3±5 3 105/well of a
Phase calculations were performed at a resolution of 2.1 AÊ using six-well dish the day before the treatment with saturating concentra-
the program MADSYS (Hendrickson, 1991). The complete data set tions of recombinant mouse TNF. Cells in each well were lysed at
at 2.0 AÊ resolution is sufficiently isomorphous with the MAD data times 0, 10, and 30 min in lysis buffer containing 20 mM Tris, pH
set to allow the direct transfer of the ABCD phase coefficients from 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton, 2.5 mM
the MAD analysis. The TRAF domain of TRAF2 structure in the sodium pyrophosphate, 1 mM b-glycerophosphate, 1 mM Na3VO4,crystal was located by molecular replacement using the REPLACE 1 mg/ml leupeptin, and 1 mM PMSF. Whole cell lysates correspond-
package (Tong, 1993). Phases calculated from this partial model ing to the same total receptor numbers were loaded onto 10% SDS-
were combined with the experimental phases from the MAD analy- polyacrylamide gels and transferred to PVDF membranes (Millipore).
sis. The combined phases were then refined and extended by sol- Blots were probed with anti-JNK and anti-phospho-JNK polyclonal
vent flattening and histogram matching using the DM program in IgG (New England Biolabs) and HRP-conjugated secondary anti-
the CCP4 suite. body. Detection was carried out using ECL plus chemiluminescence
The initial map showed recognizable secondary structures but substrate (Amersham Pharmacia).
with poor connectivity and side chain densities. Iterative model
building (Jones et al., 1991) and refinement (Brunger et al., 1998)
were necessary for sequence assignment and complete tracing of TRADD-Mediated Apoptosis Assay
the TRADD polypeptide chain (residues 8±163). The main chain Full-length wild-type TRADD was subcloned into the pCDNA3 vector
atoms of two additional residues from the His-tag (residues and single-site mutagenesis was performed and confirmed by dou-
LEHHHHHH) were also visible and built. Ribbon diagrams and stick ble-stranded DNA sequencing. The L929 cell line was maintained
models were generated using the program Setor (Evans, 1993) and in 10% bovine serum in DMEM and 1.5 3 105 cells/well were seeded
molecular surface representations were produced with the program on 6-well dishes the day before transfection. Cells were cotrans-
GRASP (Nicholls et al., 1991). fected with 4 mg of CMV-LacZ plasmid and 6 mg of either CDM8 (DNA
control), wild-type TRADD, or mutant TRADD for 48 hr. Methods for
transfection, fixing, and X-Gal staining were performed as describedSurface Plasmon Resonance Biosensor Analysis
The interaction of TRADD-N with the TRAF domain of TRAF2 was previously (Liou and Liou, 1999). The number of blue cells (both
shrunken dense-nucleated apoptotic cells and spindle-shapedanalyzed by surface plasmon resonance using a BIACORE 2000
optical biosensor (Biacore AB, Uppsala, Sweden). The TRAF domain healthy cells) were determined microscopically from eight zones on
each dish, from which the average and the standard deviation ofof TRAF2 was immobilized onto a B1 biosensor chip using amine
coupling chemistry described previously (Johnsson et al., 1991). the percentage cell death were obtained.
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